\-\ Texto\\:\\ \ \(0\)\
\-\ obtunded\\ \ \(4\)\
\-\ no\\ focal\\ signs\\ or\\ symptoms\ \(0\)\
\-\ patient\\'s\\ mental\\ status\\ improved\\ on\\ antifungal\\ medications\\.\ \(0\)\
\-\ \\â\\€\\¢\\ high\\ signal\\ t1\\ lesions\\ in\\ the\\ perivascular\\ spaces\\ bilateral\\ basal\\ ganglia\ \(0\)\
\-\ \\â\\€\\¢\\ lesions\\ enhance\\ following\\ contrast\\ administration\ \(0\)\
\-\ \\â\\€\\¢\\ minimal\\ mass\\ effect\ \(0\)\
\-\ cryptococcus\\,\\ cryptococcoma\\ \\(presumed\\)\ \(0\)\
\-\ \\â\\€\\¢\\ cryptococcus\\ meningitis\ \(0\)\
\-\ \\â\\€\\¢\\ toxoplasmosis\ \(0\)\
\-\ \\â\\€\\¢\\ hemorrhage\ \(2\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ 39\\ year\\ old\\ woman\\ s\\/p\\ bone\\ marrow\\ transplant\\ therapy\\ for\\ leukemia\\.\\ \\ decrease\\ in\\ mental\\ status\\ prompted\\ mri\\.\ \(0\)\
\-\ in\\ spite\\ of\\ brain\\ biopsy\\ and\\ multiple\\ csf\\ and\\ blood\\ samples\\ cryptococcus\\ could\\ not\\ be\\ confirmed\\.\\ \\ the\\ cause\\ of\\ the\\ high\\ signal\\ intensity\\ lesions\\ in\\ the\\ vr\\ spaces\\ is\\ likely\\ to\\ be\\ due\\ to\\ proteinaceous\\ fluid\\ in\\ the\\ pseuocapsule\\ of\\ the\\ offending\\ organism\\ \\-\\ since\\ neither\\ calcium\\ nor\\ blood\\ was\\ demonstrated\\ in\\ these\\ regions\\ on\\ a\\ contemporary\\ ct\\ scan\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cryptococcus\\:\\ 0\\.4250054690477862\ \(0\)\
\-\ spaces\\:\\ 0\\.19304675605234947\ \(0\)\
\-\ mental\\:\\ 0\\.18489397258609258\ \(0\)\
\-\ lesions\\:\\ 0\\.18276075886041626\ \(0\)\
\-\ pseuocapsule\\:\\ 0\\.16963751093938453\ \(0\)\
\-\ cryptococcoma\\:\\ 0\\.16209769799367454\ \(0\)\
\-\ in\\:\\ 0\\.1583285650344158\ \(0\)\
\-\ vr\\:\\ 0\\.1567481155740154\ \(0\)\
\-\ spite\\:\\ 0\\.1492083026283054\ \(0\)\
\-\ status\\:\\ 0\\.14805175422604497\ \(0\)\
\-\ antifungal\\:\\ 0\\.14634179878343817\ \(0\)\
\-\ contemporary\\:\\ 0\\.14634179878343817\ \(0\)\
\-\ samples\\:\\ 0\\.1438587202086463\ \(0\)\
\-\ offending\\:\\ 0\\.13793692443267866\ \(0\)\
\-\ obtunded\\:\\ 0\\.129841981702623\ \(0\)\
\-\ proteinaceous\\:\\ 0\\.129841981702623\ \(0\)\
\-\ the\\:\\ 0\\.1269952058863528\ \(0\)\
\-\ perivascular\\:\\ 0\\.12591259047235903\ \(0\)\
\-\ organism\\:\\ 0\\.12591259047235903\ \(0\)\
\-\ neither\\:\\ 0\\.12342951189756714\ \(0\)\
\-\ blood\\:\\ 0\\.12320898013948728\ \(0\)\
\-\ high\\:\\ 0\\.12057251035853822\ \(0\)\
\-\ signal\\:\\ 0\\.12026215306195401\ \(0\)\
\-\ toxoplasmosis\\:\\ 0\\.11928005340334386\ \(0\)\
\-\ prompted\\:\\ 0\\.11695258633725387\ \(0\)\
\-\ presumed\\:\\ 0\\.10834988600614713\ \(0\)\
\-\ transplant\\:\\ 0\\.10608328795274895\ \(0\)\
\-\ nor\\:\\ 0\\.10326038428441786\ \(0\)\
\-\ meningitis\\:\\ 0\\.09991373247766147\ \(0\)\
\-\ ganglia\\:\\ 0\\.09969623915886146\ \(0\)\
\-\ leukemia\\:\\ 0\\.09689161712409232\ \(0\)\
\-\ calcium\\:\\ 0\\.09580807957913459\ \(0\)\
\-\ enhance\\:\\ 0\\.09495099392663012\ \(0\)\
\-\ improved\\:\\ 0\\.09413167785036676\ \(0\)\
\-\ decrease\\:\\ 0\\.09117379560651562\ \(0\)\
\-\ regions\\:\\ 0\\.09103756447140086\ \(0\)\
\-\ basal\\:\\ 0\\.09076806023565534\ \(0\)\
\-\ medications\\:\\ 0\\.08898356508046472\ \(0\)\
\-\ 39\\:\\ 0\\.08815168025294647\ \(0\)\
\-\ marrow\\:\\ 0\\.08815168025294647\ \(0\)\
\-\ be\\:\\ 0\\.08606102398985084\ \(0\)\
\-\ administration\\:\\ 0\\.08447301821587733\ \(0\)\
\-\ csf\\:\\ 0\\.08381719071195602\ \(0\)\
\-\ minimal\\:\\ 0\\.08092440351744995\ \(0\)\
\-\ confirmed\\:\\ 0\\.07821615991952338\ \(0\)\
\-\ could\\:\\ 0\\.07715705710049232\ \(0\)\
\-\ since\\:\\ 0\\.0768380875856744\ \(0\)\
\-\ intensity\\:\\ 0\\.07532048670903002\ \(0\)\
\-\ effect\\:\\ 0\\.07441043518238992\ \(0\)\
\-\ biopsy\\:\\ 0\\.0743550090108825\ \(0\)\
\-\ signs\\:\\ 0\\.0741349417469232\ \(0\)\
\-\ cause\\:\\ 0\\.07226342840730149\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.07102008073090321\ \(0\)\
\-\ brain\\:\\ 0\\.06612706717262101\ \(0\)\
\-\ t1\\:\\ 0\\.06609154573531795\ \(0\)\
\-\ demonstrated\\:\\ 0\\.06519103061738643\ \(0\)\
\-\ on\\:\\ 0\\.06407312783572033\ \(0\)\
\-\ following\\:\\ 0\\.0636351018751875\ \(0\)\
\-\ focal\\:\\ 0\\.06344945507429278\ \(0\)\
\-\ likely\\:\\ 0\\.06338798240087688\ \(0\)\
\-\ scan\\:\\ 0\\.06293330286015486\ \(0\)\
\-\ of\\:\\ 0\\.062275405080224146\ \(0\)\
\-\ fluid\\:\\ 0\\.061245546381554064\ \(0\)\
\-\ due\\:\\ 0\\.06097407489198248\ \(0\)\
\-\ therapy\\:\\ 0\\.06094714445023911\ \(0\)\
\-\ these\\:\\ 0\\.059900709922099914\ \(0\)\
\-\ metastatic\\:\\ 0\\.05817700037521425\ \(0\)\
\-\ symptoms\\:\\ 0\\.05803839998121776\ \(0\)\
\-\ bone\\:\\ 0\\.057877994467288425\ \(0\)\
\-\ bilateral\\:\\ 0\\.057008785066064306\ \(0\)\
\-\ woman\\:\\ 0\\.0552443674891985\ \(0\)\
\-\ mri\\:\\ 0\\.054449651306422854\ \(0\)\
\-\ to\\:\\ 0\\.053037237518025096\ \(0\)\
\-\ multiple\\:\\ 0\\.05188374200771076\ \(0\)\
\-\ contrast\\:\\ 0\\.05153982661080697\ \(0\)\
\-\ disease\\:\\ 0\\.04452664615021273\ \(0\)\
\-\ and\\:\\ 0\\.04383832764894753\ \(0\)\
\-\ not\\:\\ 0\\.04187600852536046\ \(0\)\
\-\ mass\\:\\ 0\\.040517936139159966\ \(0\)\
\-\ ct\\:\\ 0\\.04038386586283934\ \(0\)\
\-\ was\\:\\ 0\\.03696829520399057\ \(0\)\
\-\ or\\:\\ 0\\.036901711006745705\ \(0\)\
\-\ patient\\:\\ 0\\.034500972751214554\ \(0\)\
\-\ no\\:\\ 0\\.03449448331936587\ \(0\)\
\-\ year\\:\\ 0\\.032690321632624586\ \(0\)\
\-\ for\\:\\ 0\\.0321506119096583\ \(0\)\
\-\ old\\:\\ 0\\.03139402480297799\ \(0\)\
\-\ is\\:\\ 0\\.02904944390672107\ \(0\)\
